北京大学学报(医学版) ›› 2021, Vol. 53 ›› Issue (6): 1067-1071. doi: 10.19723/j.issn.1671-167X.2021.06.010

• 论著 • 上一篇    下一篇

痛风患者发生关节及肌腱内晶体沉积的临床特点

彭喆1,丁亚敏1,裴林2,姚海红1,张学武1,唐素玫1,()   

  1. 1.北京大学人民医院 风湿免疫科, 北京 100044
    2.北京大学人民医院 检验科,北京 100044
  • 收稿日期:2021-09-14 出版日期:2021-12-18 发布日期:2021-12-13
  • 通讯作者: 唐素玫 E-mail:tangsumei@hotmail.com

Clinical characteristics of crystal deposits in joints and tendons in patients with gout

PENG Zhe1,DING Ya-min1,PEI Lin2,YAO Hai-hong1,ZHANG Xue-wu1,TANG Su-mei1,()   

  1. 1. Department of Rheumatology, Peking University People’s Hospital, Beijing 100044, China
    2. Department of Laboratory Medicine, Peking University People’s Hospital, Beijing 100044, China
  • Received:2021-09-14 Online:2021-12-18 Published:2021-12-13
  • Contact: Su-mei TANG E-mail:tangsumei@hotmail.com

RICH HTML

  

摘要:

目的:探讨痛风患者发生关节及肌腱内晶体沉积的临床特点,为痛风的早期诊治提供依据。方法:选择2019年6—12月在北京大学人民医院风湿免疫科连续就诊的痛风患者共105例进行回顾性分析,应用高频超声技术检测其膝、踝、足趾及其他疼痛关节和肌腱,并依据其有无尿酸钠晶体沉积以及晶体沉积部位对其进行分组,收集临床资料,并分析各组临床特点。结果:105例患者中,未检测到关节或肌腱内晶体沉积的患者共25例(无结晶组), 检测到关节内结晶的患者共43例(关节组),检测到肌腱内结晶(伴或不伴关节结晶)的患者共37例(肌腱组)。其中关节组最常累及的部位为跖趾关节(29例,67.4%),其次为膝关节(10例,23.2%)、踝关节(9例,20.9%), 此外还可见晶体沉积于腕关节(2例)、足背关节(2例)、近端指间关节(1例)。肌腱组最常累及的部位为股四头肌腱(16例,43.2%), 其次为跟腱(13例,35.1%)、髌腱(12例,32.4%)、肱三头肌腱(5例,13.5%),此外还可见晶体沉积于冈上肌腱(3例)、肩胛下肌腱(2例)、屈指肌腱(2例)、桡侧腕长伸肌腱(1例)、桡侧腕短伸肌腱(1例)、胫骨前肌腱(1例)、胫骨后肌腱(1例)、屈趾肌腱(1例)。3组间利用多样本方差分析/多样本秩和检验进行比较,患者年龄、尿酸初次升高年龄、血糖水平及C反应蛋白差异均有统计学意义;经多重比较,肌腱组年龄、尿酸初次升高年龄、C反应蛋白均显著高于无结晶组;无结晶组与关节组、肌腱组与关节组差异无统计学意义。结论:在痛风患者中,超声检测到晶体沉积于关节或肌腱是常见的,最常累及的部位包括跖趾关节、膝关节、踝关节,以及股四头肌肌腱、跟腱、髌腱、肱三头肌肌腱。3组间年龄、尿酸初次升高年龄、C反应蛋白、血糖水平差异有统计学意义,且有晶体沉积患者合并泌尿系结石的比例显著高于无结晶沉积者。

关键词: 痛风, 肌腱, 关节, 尿酸钠晶体沉积, 超声

Abstract:

Objective: To explore the abnormal manifestations and clinical features of patients with gout according to the location of crystal deposits:in articulars or in tendons. Methods: A total of 105 patients with gout who were continuously treated in the Department of Rheumatology and Immunology of Peking University People’s Hospital from June 2019 to December 2019 were selected and their knees, ankles, toes and painful joints and tendons were examined by high-frequency ultrasound. Then we grouped them according to the presence or absence of sodium urate crystals and the location of the crystals, collected their clinical data, and analyzed the clinical characteristics. Results: Among the 105 patients, 25 patients had no crystal deposits in the joints or tendons (as the non-crystal group), 43 patients had intra-articular crystals (as the joint group), and 37 patients had intra-tendon crystals with or without intra-articular crystals (as the tendon group). Among them, the most involved part of sodium urate crystals deposited in the joints was the metatarsophalangeal joint (29 cases, 67.4%), followed by knee joints (10 cases, 23.2%), ankle joints (9 cases, 20.9%). The most involved part of sodium urate crystals deposited in the tendon was the quadriceps tendon (16 cases, 43.2%), followed by the Achilles tendon (13 cases, 35.1%), the patellar tendon (12 cases, 32.4%), and the three heads of brachii tendons (5 cases, 13.5%). The three groups were compared using multi-sample analysis of variance/multi-sample rank sum test. Age, age of first increase in uric acid (UA), serum glucose (Glu) level and C reactive protein (CRP) were all significantly different. After multiple comparisons, compared with the non-crystal group, age, the age of first increase in uric acid, and CRP were significantly higher in the tendon group. There was no significant difference between the non-crystal group and the joint group. There was no significant difference between the tendon group and the joint group. Conclusion: In patients with gout, it is common for ultrasound to find crystals deposited in joints or tendons. The most commonly affected parts include the metatarsophalangeal joint, knee joint, ankle joint, quadriceps tendon, Achilles tendon, patellar tendon, and triceps tendon. There were significant differences among the three groups in age, age of first increase in uric acid, CRP and blood glucose, and the proportion of urinary calculi in patients with crystal deposits was significantly higher than those without crystal deposits.

Key words: Gout, Tendon, Joint, Sodium urate crystal deposition, Ultrasound

中图分类号: 

  • R59

表1

各组患者基本情况及尿酸水平"

Items Non-crystal (n=25) Tendon (n=37) Joint (n=43) P
Age/years 33.6±9.1 45.9±14.0a 41.1±12.7 0.001
BMI/(kg/m2) 26.5±3.2 27.4±4.2 25.9±3.8 0.246
Course of hyperuricemia/months 60.2±45.3 101.7±75.7 90.0±66.9 0.136
Age of first rise in UA/years 28.6±9.0 38.5±12.7a 34.5±10.6 0.004
Initial UA/(μmol/L) 540.4±78.3 564.5±175.7 526.2±65.2 0.649
Highest UA/(μmol/L) 604.8±65.5 632.6±130.0 607.7±101.6 0.627
Immediate UA/(μmol/L) 511.0±129.8 502.4±110.2 507.6±120.0 0.964

表2

各组患者血炎症指标水平"

Items Non-crystal (n=25) Tendon (n=37) Joint (n=43) P
ESR/(mm/h) 4.0 (3.0, 5.0) 8.0 (5.5, 25.0) 6.0 (4.0, 34.0) 0.244
CRP/(mg/L) 1.0 (0.8, 3.1) 5.3 (2.5, 11.8)a 9.4 (1.5, 19.0) 0.045

表3

各组患者血脂、血糖水平"

Items Non-crystal (n=25) Tendon (n=37) Joint (n=43) P
Glu/(mmol/L) 4.94±0.51 5.36±0.78 5.37±0.56 0.041
LDL-C/(mmol/L) 3.03±0.70 3.09±0.82 3.12±0.60 0.912
HDL-C/(mmol/L) 1.14±0.20 1.02±0.20 1.10±0.21 0.131
CHO/(mmol/L) 4.75±1.11 4.91±0.91 4.87±0.80 0.831
TG/(mmol/L) 2.14±1.18 2.33±1.39 2.19±1.48 0.867
[1] Dalbeth N, Merriman TR, Stamp LK. Gout[J]. Lancet, 2016, 388(10055):2039-2052.
doi: S0140-6736(16)00346-9 pmid: 27112094
[2] Neogi T, Jansen TL, Dalbeth N, et al. 2015 Gout classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative[J]. Ann Rheum Dis, 2015, 74(10):1789-1798.
doi: 10.1136/annrheumdis-2015-208237
[3] Liu R, Han C, Wu D, et al. Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: A systematic review and meta-analysis[J/OL]. Biomed Res Int, 2015, 2015: 762820[2021-06-01]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657091/.
[4] Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: Prevalence, incidence, treatment patterns and risk factors[J]. Nat Rev Rheumatol, 2020, 16(7):380-390.
doi: 10.1038/s41584-020-0441-1 pmid: 32541923
[5] Fisher MC, Rai SK, Lu N, et al. The unclosing premature mortality gap in gout: A general population-based study[J]. Ann Rheum Dis, 2017, 76(7):1289-1294.
doi: 10.1136/annrheumdis-2016-210588 pmid: 28122760
[6] Doherty M, Jansen TL, Nuki G, et al. Gout: Why is this curable disease so seldom cured[J]. Ann Rheum Dis, 2012, 71(11):1765-1770.
doi: 10.1136/annrheumdis-2012-201687
[7] Wang Y, Deng X, Xu Y, et al. Detection of uric acid crystal deposition by ultrasonography and dual-energy computed tomography: A cross-sectional study in patients with clinically diagnosed gout[J]. Medicine (Baltimore), 2018, 97(42):e12834.
doi: 10.1097/MD.0000000000012834
[8] Bayat S, Baraf HSB, Rech J. Update on imaging in gout: Contrasting and comparing the role of dual-energy computed tomography to traditional diagnostic and monitoring techniques[J]. Clin Exp Rheumatol, 2018, 114(5):53-60.
[9] Yuan Y, Liu C, Xiang X, et al. Ultrasound scans and dual energy CT identify tendons as preferred anatomical location of MSU crystal depositions in gouty joints[J]. Rheumatol Int, 2018, 38(5):801-811.
doi: 10.1007/s00296-018-3994-4 pmid: 29442150
[10] Naredo E, Uson J, Jiménez-Palop M, et al. Ultrasound-detected musculoskeletal urate crystal deposition: Which joints and what findings should be assessed for diagnosing gout[J]. Ann Rheum Dis, 2014, 73(8):1522-1528.
[11] 王昱, 邓雪蓉, 季兰岚, 等. 超声检测痛风患者肌腱受累的危险因素和诊断价值[J]. 北京大学学报(医学版), 2021, 53(1):143-149.
[12] Andia I, Abate M. Hyperuricemia in tendons[J]. Adv Exp Med Biol, 2016, 920:123-132.
[13] Thampatty BP, Li H, Im HJ, et al. EP4 receptor regulates collagen type-I, MMP-1, and MMP-3 gene expression in human tendon fibroblasts in response to IL-1 beta treatment[J]. Gene, 2007, 386(1/2):154-161.
doi: 10.1016/j.gene.2006.08.027
[14] Goldberg EL, Dixit VD. Drivers of age-related inflammation and strategies for healthspan extension[J]. Immunol Rev, 2015, 265(1):63-74.
doi: 10.1111/imr.12295 pmid: 25879284
[15] Alberts A, Klingberg A, Wessig AK, et al. C-reactive protein (CRP) recognizes uric acid crystals and recruits proteases C1 and MASP1[J]. Sci Rep, 2020, 10(1):6391.
doi: 10.1038/s41598-020-63318-8 pmid: 32286427
[16] Renaudin F, Orliaguet L, Castelli F, et al. Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1β activation on macrophages[J]. Ann Rheum Dis, 2020, 79(11):1506-1514.
doi: 10.1136/annrheumdis-2020-217342
[17] Vazirpanah N, Ottria A, van der Linden M, et al. mTOR inhibition by metformin impacts monosodium urate crystal-induced inflammation and cell death in gout: A prelude to a new add-on therapy[J]. Ann Rheum Dis. 2019, 78(5):663-671.
doi: 10.1136/annrheumdis-2018-214656 pmid: 30814053
[18] Roughley MJ, Belcher J, Mallen CD, et al. Gout and risk of chronic kidney disease and nephrolithiasis: Meta-analysis of observational studies[J]. Arthritis Res Ther, 2015, 17(1):90.
doi: 10.1186/s13075-015-0610-9
[1] 原晋芳, 王新利, 崔蕴璞, 王雪梅. 尿促黄体生成素在女童中枢性性早熟预测中的应用[J]. 北京大学学报(医学版), 2024, 56(5): 788-793.
[2] 汪琪伟, 包鹏宇, 洪士皓, 杨昕, 王宇, 曹永平. 改良股骨颈截骨术在伴严重屈曲畸形强直性脊柱炎患者手术治疗过程中的疗效[J]. 北京大学学报(医学版), 2024, 56(5): 884-889.
[3] 刘东武, 陈杰, 高明利, 于静. 类风湿关节炎伴发淋巴结Castleman样病理改变1例[J]. 北京大学学报(医学版), 2024, 56(5): 928-931.
[4] 王明瑞,刘军,熊六林,于路平,胡浩,许克新,徐涛. 经皮微通道-微电子肾镜-微超声探针碎石术治疗1.5~2.5 cm肾结石的疗效和安全性[J]. 北京大学学报(医学版), 2024, 56(4): 605-609.
[5] 杨捷,冯杰莉,张树栋,马潞林,郑清. 经食管超声心动图在肾切除术联合Mayo Ⅲ~Ⅳ级静脉瘤栓取栓术不同手术方式中的临床作用[J]. 北京大学学报(医学版), 2024, 56(4): 631-635.
[6] 陈延,李况蒙,洪锴,张树栋,程建星,郑仲杰,唐文豪,赵连明,张海涛,姜辉,林浩成. 阴茎海绵体注射试验对阴茎血管功能影响的回顾性研究[J]. 北京大学学报(医学版), 2024, 56(4): 680-686.
[7] 李正芳,罗采南,武丽君,吴雪,孟新艳,陈晓梅,石亚妹,钟岩. 抗氨基甲酰化蛋白抗体在诊断类风湿关节炎中的应用价值[J]. 北京大学学报(医学版), 2024, 56(4): 729-734.
[8] 黄会娜,赵静,赵祥格,白自然,李霞,王冠. 乳酸对类风湿关节炎患者外周血CD4+T细胞亚群的调控作用[J]. 北京大学学报(医学版), 2024, 56(3): 519-525.
[9] 汤晓菲,李永红,丁秋玲,孙卓,张阳,王育梅,田美伊,刘坚. 类风湿关节炎患者下肢深静脉血栓发病率及危险因素[J]. 北京大学学报(医学版), 2024, 56(2): 279-283.
[10] 李文菁,张保宙,李恒,赖良鹏,杜辉,孙宁,龚晓峰,李莹,王岩,武勇. 胫距跟融合治疗终末期踝和后足病变的中短期临床结果[J]. 北京大学学报(医学版), 2024, 56(2): 299-306.
[11] 李红光,韩玮华,吴训,冯继玲,李刚,孟娟红. 关节腔冲洗联合液态浓缩生长因子注射治疗单侧颞下颌关节骨关节炎的初步研究[J]. 北京大学学报(医学版), 2024, 56(2): 338-344.
[12] 安思兰,郑群怡,王锴,高姗. 全膝关节置换术后患者早期疼痛的特点及其影响因素[J]. 北京大学学报(医学版), 2024, 56(1): 167-173.
[13] 邹雪,白小娟,张丽卿. 艾拉莫德联合托法替布治疗难治性中重度类风湿关节炎的疗效[J]. 北京大学学报(医学版), 2023, 55(6): 1013-1021.
[14] 魏越,姚兰,陆希,王军,蔺莉,刘鲲鹏. 胃超声检查评估剖宫产产妇术前饮用碳水化合物后胃排空的效果[J]. 北京大学学报(医学版), 2023, 55(6): 1082-1087.
[15] 吴琦,蔡月明,何娟,黄文蒂,王庆文. 血脂异常与类风湿关节炎肺间质病变的相关性分析[J]. 北京大学学报(医学版), 2023, 55(6): 982-992.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!